Steiner discusses enobosarm for muscle preservation in older obesity patients.
Veru Inc. (VERU) News
Latest headlines that mention VERU, newest first · each headline opens the original publisher
- Last price
- $2.21
- Day change
- -1.34%
- Next earnings
- 2026-12-16
VERU headlines
latest coverageVeru (VERU) stock has not been easy to own. The little biotech has spent years persuading investors that its experimental obesity technique can matter in a market dominated by giants. That's a tough sell with Novo Nordisk (NVO) and Eli Lilly (LLY) already owning the narrative…
Image source: The Motley Fool. Wednesday, May 13, 2026 at 8 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading
VERU news alerts
Get an alert by email or push when a new headline mentions VERU.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.